Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Pro-Inflammatory Biomarkers in Acute ACL Tear
NCT03389685Phase 2Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Sep 2018
- Primary completion
- Feb 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma in anterior cruciate ligament injury, sponsored by NYU Langone Health. Planned start Sep 2018; status: withdrawn.
02
Drugs
autologous platelet-rich plasma
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT03389685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389685.